Clinical Trial Update: Cannabidiol Effects on Learning and Anxiety [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial at the University of Connecticut is evaluating cannabidiol's effects on learning and anxiety, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Connecticut | Conditions: Anxiety and Fear | EARLY_Phase 1 | Status: RECRUITING